Favipiravir
Favipiravir (T-705) is a potent viral RNA polymerase inhibitor, it is phosphoribosylated by cellular enzymes to its active form, Favipiravir-ribofuranosyl-5′-triphosphate (RTP) . Favipiravir-RTP inhibits the influenza viral RNA-dependent RNA polymerase (RdRP) activity with an IC50 of 341 nM.
Product Specifications
CAS Number
[259793-96-9]
Product Name Alternative
T-705
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H332, H335
Target
Bacterial; DNA/RNA Synthesis; Influenza Virus; SARS-CoV
Type
Reference compound
Related Pathways
Anti-infection; Cell Cycle/DNA Damage
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/T_705.html
Purity
99.98
Solubility
DMSO : 100 mg/mL (ultrasonic) |H2O : 6.25 mg/mL (ultrasonic)
Smiles
O=C(N)C1=NC(F)=CNC1=O
Molecular Formula
C5H4FN3O2
Molecular Weight
157.10
Precautions
H302, H315, H319, H332, H335
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Launched
Available Sizes
Explore Other Products
Browse additional items from our catalog
EFHD1 (EF-hand Domain-containing Protein D1, EF-hand Domain-containing Protein 1, Swiprosin-2, SWS2, PP3051) (AP) discontinued
Recombinant Human ENTPD3 Protein, His (Fc)-Avi-tagged
